Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis

BACKGROUND: Children with inflammatory bowel disease (IBD) or autoimmune hepatitis (AIH) are at risk for severe infections. This is partially a result of their chronic disease condition but, moreover, a side effect of their immunosuppressive therapy. Currently, vaccinations with live vaccines are re...

Descripción completa

Detalles Bibliográficos
Autores principales: Schleker, Teresa, Jacobsen, Eva-Maria, Mayer, Benjamin, Strauss, Gudrun, Debatin, Klaus-Michael, Posovszky, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775189/
https://www.ncbi.nlm.nih.gov/pubmed/29352427
http://dx.doi.org/10.1186/s40348-018-0079-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775189/
https://www.ncbi.nlm.nih.gov/pubmed/29352427
http://dx.doi.org/10.1186/s40348-018-0079-0

Ejemplares similares